Arkansas Department of Finance and Administration (ASC) · Arkansas
AR Securities Ad
Arkansas securities sales literature must not use unsupported comparisons or superlatives and must balance return claims with risk.
Ark. Code Ann. § 23-42-507(2)
What is AR Securities Ad?
Arkansas securities sales literature must not use unsupported comparisons or superlatives and must balance return claims with risk. Apply to Arkansas-directed securities sales literature, ads and emails for specific offerings. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability and any exceptions before making a compliance decision. Confirm
Claims that a prescription product is safer, more effective, the only or the first compared with other products require substantial evidence, normally head-to-head data, and must be accurately qualified; compounded drugs must not be marketed as FDA-approved or equivalent to a brand.
Request a free compliance scan of your homepage and book a time with Warrant.